Table 1.
Parameter | Respondents (n = 883) | |
---|---|---|
Country of residence, % (n/total) | North America | 18.9 (167) |
Latin America | 18.7 (165) | |
Europe | 46.2 (408) | |
Africa/Middle-East | 3.8 (34) | |
Asia-Pacific | 12.4 (109) | |
Specialty, % (n/total) | Allergy/Immunology | 76.8 (674/877) |
Dermatology | 22.1 (194/877) | |
Pediatrics | 10.7 (94/877) | |
Rheumatology | 3.2 (28/877) | |
General practice | 1.9 (17/877) | |
Other | 3.9 (34/877) | |
>1 specialty indicated by the same respondent | 16.3 (143/877) | |
Place of work, % (n/total) | Private practice | 47.7 (420/879) |
University clinic | 41.2 (362/879) | |
Hospital | 36.8 (324/879) | |
Specialized urticaria centre | 3.9 (35/879) | |
Other | 2.9 (26/879) | |
>1 place of work indicated by the same respondent | 24.8 (218/879) | |
Years of practice, median (IQR) | 15 (7–26) | |
Number of patients with urticarial vasculitis seen per year, median (IQR) | 5 (2–10) |
IQR: interquartile range